Oncotarget

Research Papers:

ZBRK1, a novel tumor suppressor, activates VHL gene transcription through formation of a complex with VHL and p300 in renal cancer

Ke Chen _, Gan Yu, Kiranmai Gumireddy, Anping Li, Weimin Yao, Lu Gao, Shuliang Chen, Jun Hao, Ji Wang, Qihong Huang, Hua Xu and Zhangqun Ye

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:6959-6976. https://doi.org/10.18632/oncotarget.3134

Metrics: PDF 1335 views  |   HTML 1963 views  |   ?  


Abstract

Ke Chen1,2,*, Gan Yu1,2,*, Kiranmai Gumireddy3, Anping Li3, Weimin Yao1,2, Lu Gao4, Shuliang Chen5, Jun Hao6, Ji Wang7, Qihong Huang3, Hua Xu1,2, Zhangqun Ye1,2

1Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

2Institute of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

3The Wistar Institute, Philadelphia, PA, USA

4Department of Cardiology, Institute of Cardiovascular Disease, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

5School of Basic Medical Sciences, Wuhan University, Wuhan, China

6Cardiovascular Research Institute of Wuhan University, Wuhan, China

7Department of Cell Death and Cancer Genetics, The Hormel Institute, University of Minnesota, Austin, MN, USA

*These authors have contributed equally to this work

Correspondence to:

Hua Xu, e-mail: xuhuawhu@163.com

Keywords: ZBRK1, VHL, p300, renal cancer, tumor suppressor

Received: September 12, 2014     Accepted: January 10, 2015     Published: February 10, 2015

ABSTRACT

Inactivation or mutation of the VHL gene causes various tumors, including clear cell renal cell carcinoma (ccRCC). In the present study, we identified ZBRK1 as a novel VHL interacting protein by yeast two-hybrid screening, and found a single ZBRK1-binding site located in the VHL promoter region. Ectopic expression of ZBRK1 increases transcriptional activity of the VHL, whereas the depletion of endogenous ZBRK1 by shRNA leads to reduction of VHL expression. We also demonstrate that the inhibition of VEGF transcription by ZBRK1 overexpression is dependent on VHL/HIF pathway. Moreover, VHL is confirmed to serve as a bridge component for the association of ZBRK1 and p300, which leads to an increase in ZBRK1 transcriptional activity in the VHL promoter. We further provide striking evidences that ZBRK1 acts as a tumor suppressor in renal carcinoma by a variety of in vitro and in vivo assays, and ZBRK1 may represent a molecular marker to distinguish patients with ccRCC at high risk from those with a better survival prognosis. Taken together, these findings suggest that ZBRK1 suppresses renal cancer progression perhaps by regulating VHL expression.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 3134